Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

69
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
69
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

57
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
57
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

129
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
129
Decision Making: P-value Method01:09

Decision Making: P-value Method

5.2K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.2K
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

99
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
99
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

90
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
90

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

From Data to Knowledge. Advancing Life Sciences: Editorial for the CEN2023 Special Issue.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

AI-driven reclassification of multiple sclerosis progression.

Nature medicine·2025
Same author

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Performance of Composite Endpoints Defining Progression Independent of Relapse Activity in Multiple Sclerosis.

Annals of clinical and translational neurology·2025
Same author

Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data.

Multiple sclerosis and related disorders·2025

相关实验视频

Updated: May 13, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

徒劳性临时分析 - - 简单性的理由

Gian-Andrea Thanei1, Gaëlle Klingelschmitt2, Claude Berge2

  • 1Product Development Data Sciences, Pharma Development, Roche, Basel, Switzerland. gian-andrea.thanei@roche.com.

Therapeutic innovation & regulatory science
|April 14, 2025
PubMed
概括

徒劳性中间分析可以负担得起地降低药物开发风险,但由于担心过早终止而未得到充分利用. 这项研究提供了一个简单的策略,以更好地理解和管理临床试验中徒劳性风险.

科学领域:

  • 临床药物开发 临床药物开发
  • 生物统计学 生物统计学
  • 药学研究 药学研究

背景情况:

  • 徒劳性中间分析对于创新疗法开发中的风险管理至关重要.
  • 这些分析未得到充分利用,因为团队担心可能会终止成功的治疗方法.
  • 当前的规划通常涉及复杂的统计建模,阻碍了可访问性.

研究的目的:

  • 提出一个简单的策略,在临床试验中建立无效值.
  • 引入一种直观的衡量方法来评估徒劳风险.
  • 简化药物开发中无用性分析的理解和应用.

主要方法:

  • 开发一个简单的策略来定义无用度值的范围.
  • 介绍了一种新的,直观的徒劳风险测量方法.
  • 专注于开发团队的清晰沟通和风险评估.

主要成果:

  • 提出了一种简化方法来设定无用度值.
  • 一个直观的风险测量有助于评估徒劳的可能性.
  • 拟议的方法旨在消除开发团队的徒劳性分析的神秘性.

结论:

关键词:
临床药物开发 临床药物开发徒劳性的中间分析.虚无的风险 虚无的风险运行特征 运行特征追溯的徒劳性分析.

更多相关视频

High-Throughput Screening of Microbial Isolates with Impact on Caenorhabditis elegans Health
11:40

High-Throughput Screening of Microbial Isolates with Impact on Caenorhabditis elegans Health

Published on: April 28, 2022

2.6K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.1K

相关实验视频

Last Updated: May 13, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
High-Throughput Screening of Microbial Isolates with Impact on Caenorhabditis elegans Health
11:40

High-Throughput Screening of Microbial Isolates with Impact on Caenorhabditis elegans Health

Published on: April 28, 2022

2.6K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.1K
  • 与徒劳性中间分析相关的高估风险可以减轻.
  • 一个简单的策略和直观的测量可以改善无用性分析的采用和理解.
  • 增强的沟通和简化工具可以使临床开发团队能够更有效地利用徒劳性分析.